372 related articles for article (PubMed ID: 19615802)
21. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
Nakatani K; Asai O; Konishi N; Iwano M
Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685
[TBL] [Abstract][Full Text] [Related]
22. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
[TBL] [Abstract][Full Text] [Related]
23. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
Srivastava SP; Zhou H; Setia O; Dardik A; Fernandez-Hernando C; Goodwin J
J Am Heart Assoc; 2021 Aug; 10(15):e019437. PubMed ID: 34308664
[TBL] [Abstract][Full Text] [Related]
24. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
25. A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy.
Kimura M; Toyoda M; Saito N; Kaneyama N; Miyatake H; Tanaka E; Komaba H; Hara M; Fukagawa M
J Diabetes Res; 2019; 2019():9475637. PubMed ID: 30911554
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
28. Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis.
Boini KM; Xia M; Xiong J; Li C; Payne LP; Li PL
J Cell Mol Med; 2012 Aug; 16(8):1674-85. PubMed ID: 21992601
[TBL] [Abstract][Full Text] [Related]
29. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
[TBL] [Abstract][Full Text] [Related]
30. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
[TBL] [Abstract][Full Text] [Related]
31. HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.
Yadav A; Vallabu S; Kumar D; Ding G; Charney DN; Chander PN; Singhal PC
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F734-44. PubMed ID: 20015943
[TBL] [Abstract][Full Text] [Related]
32. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
[TBL] [Abstract][Full Text] [Related]
33. Collapsing glomerulopathy superimposed on diabetic nephropathy: insights into etiology of an under-recognized, severe pattern of glomerular injury.
Salvatore SP; Reddi AS; Chandran CB; Chevalier JM; Okechukwu CN; Seshan SV
Nephrol Dial Transplant; 2014 Feb; 29(2):392-9. PubMed ID: 24081860
[TBL] [Abstract][Full Text] [Related]
34. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
35. PRMT1 mediates podocyte injury and glomerular fibrosis through phosphorylation of ERK pathway.
Zhu Y
Biochem Biophys Res Commun; 2018 Jan; 495(1):828-838. PubMed ID: 29129692
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
37. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
38. Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics.
Hara M; Oohara K; Dai DF; Liapis H
Am J Pathol; 2019 Feb; 189(2):248-257. PubMed ID: 30472210
[TBL] [Abstract][Full Text] [Related]
39. C3a receptor blockade protects podocytes from injury in diabetic nephropathy.
Morigi M; Perico L; Corna D; Locatelli M; Cassis P; Carminati CE; Bolognini S; Zoja C; Remuzzi G; Benigni A; Buelli S
JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32161193
[TBL] [Abstract][Full Text] [Related]
40. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
